Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice

Claire M. Koenig, Cheryl K. Walker, Lihong Qi, Isaac N Pessah, Robert F Berman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 μg/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth.

Original languageEnglish (US)
Article numbere38911
JournalPLoS One
Volume7
Issue number6
DOIs
StatePublished - Jun 13 2012

Fingerprint

Misoprostol
Toxicity
toxicity
mice
dosage
labor
developmental stages
Parturition
pregnancy
Personnel
uterine contraction
Stereotyped Behavior
synthetic prostaglandins
Synthetic Prostaglandins
Uterine Contraction
Pregnancy
stereotyped behavior
Alprostadil
anxiety
Interpersonal Relations

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice. / Koenig, Claire M.; Walker, Cheryl K.; Qi, Lihong; Pessah, Isaac N; Berman, Robert F.

In: PLoS One, Vol. 7, No. 6, e38911, 13.06.2012.

Research output: Contribution to journalArticle

@article{a6e05138d85a46daa9f73f5859ef6d27,
title = "Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice",
abstract = "Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 μg/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth.",
author = "Koenig, {Claire M.} and Walker, {Cheryl K.} and Lihong Qi and Pessah, {Isaac N} and Berman, {Robert F}",
year = "2012",
month = "6",
day = "13",
doi = "10.1371/journal.pone.0038911",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice

AU - Koenig, Claire M.

AU - Walker, Cheryl K.

AU - Qi, Lihong

AU - Pessah, Isaac N

AU - Berman, Robert F

PY - 2012/6/13

Y1 - 2012/6/13

N2 - Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 μg/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth.

AB - Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 μg/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth.

UR - http://www.scopus.com/inward/record.url?scp=84862174194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862174194&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0038911

DO - 10.1371/journal.pone.0038911

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e38911

ER -